Ozzy Osbourne shares health update amid Parkinson's battle ahead of Black Sabbath show
The heavy metal singer has opened up about his health battles as tickets go on sale for the Back To The Beginning gig ...
Ozzy Osbourne opens up about health challenges in update ahead of Villa show
Black Sabbath frontman Ozzy Osbourne has spoken about his health amid presale tickets being released for the band's Back to ...
JD Vance's 12-year-old relative denied heart transplant over COVID vaccine status
Adaline Deal was born with two rare heart conditions. Her family claims she was denied a heart transplant because she is not ...
JD Vance's Relative, 12, Denied Heart Transplant Due To Vaccination Status
A 12-year-old Indiana girl was denied a heart transplant because she was not vaccinated against COVID-19 and flu. Adaline, a ...
Anavex Life Sciences Reports Fiscal 2025 First Quarter Financial Results and Provides Business Update
Company to host a webcasttoday at 8:30 a.m. Eastern TimeNEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the ...
Politifact7h
In Context: What Sen. John Kennedy said about Medicaid recipients and work requirements
Adding work requirements for people on Medicaid was a hot topic of debate during President Donald Trump’s first administration — and it may be again in Trump’s second term. Sen. John Kennedy, a ...
Acadia Pharmaceuticals: Good Progress Means I'm Reversing My 'Sell' Call To 'Buy'
Acadia Pharmaceuticals' forecasted revenues top $1bn in 2025. Find out why ACAD stock is a "Buy" with its profitable outlook ...
Anavex Life Sciences Corp.: Anavex Life Sciences Reports Fiscal 2025 First Quarter Financial Results and Provides Business Update
Company to host a webcast today at 8:30 a.m. Eastern Time NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (Nasdaq: AVXL), a clinical-stage biopharmac ...
Lifestyle News Live Today February 12, 2025: Guillain-Barre Syndrome and paralysis: What's the connection?
Stay informed with Hindustan Times' live updates! Track the latest lifestyle news including fashion trends, style guide & ...
Anavex projects EMA feedback on Alzheimer's drug by year-end 2025
Bishop asked about upcoming events. Missling outlined the anticipated schizophrenia trial readout for ANAVEX 3-71 in the first half of 2025, the detailed ATTENTION-AD data presentation in April, and ...
Anavex Out with Financial Results
Anavex Life Sciences Corp. (NASDAQ: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, ...